Changes in Antiemetic Overuse in Response to Choosing Wisely Recommendations

被引:19
|
作者
Encinosa, William [1 ]
Davidoff, Amy J. [2 ,3 ]
机构
[1] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, 5600 Fishers Ln, Rockville, MD 20857 USA
[2] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[3] Yale Canc Ctr, Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res Ctr, New Haven, CT USA
基金
美国医疗保健研究与质量局;
关键词
CHEMOTHERAPY-INDUCED NAUSEA; TOP; 5; LIST; AMERICAN SOCIETY; CLINICAL ONCOLOGY; LUNG-CANCER; COST; CARE; ADHERENCE; EMETOGENICITY;
D O I
10.1001/jamaoncol.2016.2530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMPORTANCE Antiemetics are used to prevent chemotherapy-induced nausea and vomiting in patients with cancer. Newer antiemetic agents (serotonin and neurokinin-1 receptor antagonists) have increased efficacy but are expensive. The American Society of Clinical Oncology's first guideline in the 2013 Choosing Wisely (CW) campaign discouraged overuse of expensive antiemetics in patients with low risk of chemotherapy-induced nausea and vomiting. However, little is known about patterns or trends in antiemetic overuse or whether any change has occurred with the publication of the CW recommendations. OBJECTIVE To estimate the baseline prevalence, trends, determinants, and costs of antiemetic overuse from January 1, 2008, through March 31, 2015. DESIGN, SETTING, AND PARTICIPANTS From January 1, 2008, through March 31, 2015, this observational study applied descriptive (univariate and bivariate) and multivariable logistic regression analyses to longitudinal health insurance enrollment and nationwide MarketScan insurance claims data for 678 220 privately insured patients receiving chemotherapy before and after the October 29, 2013, announcement of the CW guidelines. The baseline prevalence, trends, determinants, and costs of antiemetic overuse were estimated in cases stratified by risk for chemotherapy-induced nausea and vomiting. MAIN OUTCOMES AND MEASURES Antiemetic use, overuse measure, and expenses before and after the publication of the CW recommendation, with adjustment for patient and health care professional characteristics. RESULTS The sample included 678 220 adults who started chemotherapy during the observation period. The average age of the sample was 59.5 years, with 58.2%(n = 394 724) female. Antiemetic overuse occurred in 24.1%(n = 163 451) of patients, with highest rates among those receiving intravenous chemotherapy with high chemotherapy-induced nausea and vomiting risk (32.4%[n = 106 795]). Compared with baseline before the CW, patients had 7.0% lower odds of antiemetic overuse (95% CI, 4.4%-9.5%) during the 6 months after the CW, but this decrease was transitory: the odds of antiemetic overuse were 7.4%(95% CI, 4.6%-10.2%) higher than baseline at 6 months after the CW. Low-risk intravenous chemotherapy agents had overuse that continued to decrease 6 months after the CW. Antiemetic overuse was associated with higher costs. Reducing antiemetic overuse could have paid for 6.1%(95% CI, 5.8%-6.4%) of the chemotherapy drug costs. CONCLUSIONS AND RELEVANCE Antiemetic overuse is prevalent and results in unnecessary spending associated with systemic chemotherapy treatment. Short-term decreases in antiemetic overuse were associated with the CW recommendation, but sustained decreases occurred in only one risk group.
引用
收藏
页码:320 / 326
页数:7
相关论文
共 50 条
  • [1] Choosing Wisely Germany - Top 5 Recommendations on Overuse in Geriatric Medicine in Germany
    Gogol, M.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2016, 49 : S110 - S110
  • [2] A Choosing Wisely Initiative Against Overuse
    Glechner, Anna
    PADIATRIE UND PADOLOGIE, 2019, 54 (SUPPL 1): : S61 - S64
  • [3] Choosing wisely recommendations in gastroenterology
    Koop, H.
    Jansen, P. Lynen
    Zeuzem, S.
    INTERNIST, 2017, 58 (06): : 539 - 544
  • [4] Choosing Wisely Canada recommendations
    Meyer, Anthon
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (08) : 579 - 579
  • [5] Choosing Wisely Canada recommendations
    Behroozan, Sepideh
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (11) : 802 - 802
  • [6] Choosing Wisely Canada recommendations
    Theriault, Guylene
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (11) : 825 - 825
  • [7] Choosing Wisely Canada recommendations
    Woodhouse, Doug
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (08) : 555 - 555
  • [8] Choosing wisely recommendations in cardiology
    Werdan, K.
    Baldus, S.
    Frey, N.
    Nixdorff, U.
    Kuck, K. -H.
    Katus, H.
    INTERNIST, 2017, 58 (06): : 556 - 567
  • [9] The Overuse of Diagnostic Imaging and the Choosing Wisely Initiative
    Rao, Vijay M.
    Levin, David C.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (08) : 574 - +
  • [10] Reducing overuse in healthcare: advancing Choosing Wisely
    Born, Karen
    Kool, Tijn
    Levinson, Wendy
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 367